Driada Medical CJC1295 with DAC 2mg

£29.00

Description
Reviews (0)

Driada Medical CJC1295 with DAC 2mg

Driada Medical CJC1295 with DAC 2mg is a synthetic Growth Hormone Releasing Hormone (GHRH) analog engineered for sustained elevation of growth hormone and IGF-1 levels. The addition of Drug Affinity Complex (DAC) technology binds the peptide to serum albumin, extending its half-life from mere minutes to approximately 8 days. This extended duration eliminates the need for multiple daily injections required by standard GRF 1-29, providing continuous GH stimulation with weekly administration. Clinical research confirms CJC–1295 DAC significantly increases protein synthesis and promotes substantial fat loss without elevating prolactin levels. Originally developed for AIDS-related wasting conditions, this compound has become essential for athletes seeking sustained anabolic signaling, improved recovery, and enhanced body composition through optimized endocrine function.

Key Features

Contains 2mg of CJC-1295 with DAC (Drug Affinity Complex)
DAC technology extends half-life to approximately 8 days through albumin binding
Stimulates significant increases in growth hormone and IGF-1 secretion
Does not elevate prolactin levels, avoiding associated side effects
Promotes substantial protein synthesis and muscle tissue development
Accelerates fat loss through enhanced lipolysis and metabolic optimization
Weekly injection schedule provides convenience versus multiple daily doses
Protects peptide from enzymatic degradation, ensuring sustained activity
Ideal for long-term GH elevation protocols and body composition improvement
Manufactured by Driada Medical under strict pharmaceutical quality standards

Where to Buy

Available through specialized peptide distributors and verified research suppliers
Purchase only from sources providing holographic security seals and batch verification
Verify authenticity via the official Driada Medical portal before administration
Request Certificate of Analysis (COA) to confirm DAC conjugation efficiency and purity
Avoid unregulated markets containing non-DAC variants or degraded peptides

Product Specifications

Active Ingredient: CJC-1295 with DAC (Drug Affinity Complex)
Concentration: 2mg per vial (lyophilized powder)
Sequence: Modified GRF 1-29 with DAC moiety attached
Form: Lyophilized powder requiring reconstitution with sterile water
Storage: Store lyophilized at 2-8°C; reconstituted solution stable 28-30 days refrigerated
Administration: Subcutaneous or intramuscular injection
Half-life: Approximately 6-8 days (DAC-extended versus 30 minutes for GRF 1-29)
Detection Time: Research chemical; prohibited by WADA for competitive sports

Mechanism of Action

CJC-1295 with DAC functions as a GHRH analog, binding to receptors on somatotroph cells in the anterior pituitary. The DAC moiety creates a reversible binding to serum albumin, protecting the peptide from renal clearance and enzymatic degradation. This albumin-bound complex slowly releases active peptide, creating sustained GH elevation rather than pulsatile spikes. The peptide stimulates GH synthesis and release without affecting prolactin, cortisol, or other pituitary hormones. The extended half-life maintains elevated GH and IGF-1 levels continuously, creating an anabolic environment superior to standard GHRH variants requiring frequent administration.

Metabolic Impact

The compound creates profound anabolic shifts through sustained GH elevation. It enhances protein synthesis rates, supporting muscle hypertrophy and tissue repair over extended periods. The elevated IGF-1 promotes nitrogen retention and cellular regeneration throughout the body. Fat oxidation increases significantly as GH mobilizes fatty acids from adipose tissue for energy utilization. Users experience improved sleep quality, enhanced collagen synthesis for joint health, and accelerated recovery between training sessions. The continuous elevation avoids the peaks and troughs of pulsatile GH release, maintaining stable anabolic signaling. However, the sustained elevation may cause GH desensitization over time, requiring cycling protocols.

Conclusion

Driada Medical CJC1295 with DAC 2mg delivers the most convenient and sustained GH elevation technology available. The 8-day half-life eliminates injection frequency burdens while maintaining continuous anabolic signaling. Its ability to increase GH and IGF-1 without prolactin elevation makes it superior for long-term body composition improvement. However, the extended duration requires careful monitoring to prevent receptor desensitization.

Safety Warning

CJC-1295 with DAC may cause water retention, numbness in extremities, and potential GH receptor desensitization with prolonged use. Side effects include injection site reactions and mild fatigue. This product is not for recreational use. Consult a licensed physician before administration. Do not use if pregnant, nursing, or under 21 years old. Regular monitoring is mandatory. This information is provided for educational purposes only. Actually using this product without medical supervision is illegal in many jurisdictions and could land you in serious legal trouble.